PTGS2 and esophageal cancer: Using a combination of techniques that included expression profiling, bioinformatics and investigation of identified markers in ZD:Cox-2−/− mouse models of oral-esophageal cancers, our data document a mechanism for the inability of COX-2 blockade to prevent tumor growth under ZD conditions.